| Released | Contributor | Author | Title | Pages | Price |
| 26-Nov-2009 | Pechala's Reports | Lubomir Pechala | MARSHALL EDWARDS INC (MSHL=US) - REPORT FOR ACTIVE TRADERS | 4 |
$25 |
| 24-Nov-2009 | ValuEngine, Inc. |
N/A
| ValuEngine Industry Report for DRUGS | 18 |
$49 |
| 21-Nov-2009 | Standard & Poor's Quantitative Report |
N/A
| Marshall Edwards | 4 |
$25 |
| 20-Nov-2009 | Pechala's Reports | Lubomir Pechala | MARSHALL EDWARDS INC (MSHL=US) 2-weeks forecast | 1 |
$10 |
| 20-Nov-2009 | Pechala's Reports | Frantisek Pechala | MARSHALL EDWARDS INC (MSHL=US) 12-months forecast | 1 |
$15 |
| 19-Nov-2009 | Ford Investor Services, Inc. |
N/A
| Value Graph: MARSHALL EDWARDS -- MSHL | 1 |
$4 |
| 19-Nov-2009 | Ford Investor Services, Inc. |
N/A
| Industry Value Graph: ARYX , DSCO , HEPH , ICGN , MSHL , OGXI , PIP , SOMX -- DRUGS | 3 |
$4 |
| 3-Nov-2009 | EconomicInvestor |
N/A
| "The Economy Matters" Report for MSHL: the economy's impact on MSHL's price and risk, featuring the powerful EconomicInvestor Star Rating | 6 |
$15 |
0.29% Nasdaq 
Research Reports
